In response to a JAMA Viewpoint offering 4 principles for public health post COVID, I say yes, but we need a 5th principle – Science staying in its lane.
Time for a temporarily privatized CDC policymaking process, sponsored and funded by provider & payer organizations, professional societies and states.
Where Group Dynamics meets Analysis and Design: The importance of conceptual clarity and acknowledgement of complexity.
Trump/Musk killed AHRQ, but in a sense, the death has been playing out over 25 years. Recalling 4 eras of the agency and my dream for its eventual rebirth.
In the debate about price vs utilization as the main driver of geographic variation in cost of care, I say don’t get distracted from innovation.
Recent nomination of anti-science leaders for HHS and CMS is a wake-up call. We need to defend science by staying in our lane to rebuild trust and objectivity.
Physicians want fewer quality measures, but more might be better if it motivates core process improvement rather than “studying for the test”
In response to a JAMA Viewpoint offering 4 principles for public health post COVID, I say yes, but we need a 5th principle – Science staying in its lane. Dr. Ward December 7, 2025
Health systems need to partner with universities to solve the inadequate supply of analytic talent Dr. Ward September 28, 2025
Time for a temporarily privatized CDC policymaking process, sponsored and funded by provider & payer organizations, professional societies and states. Dr. Ward September 2, 2025
Where Group Dynamics meets Analysis and Design: The importance of conceptual clarity and acknowledgement of complexity. Dr. Ward May 21, 2025
Trump/Musk killed AHRQ, but in a sense, the death has been playing out over 25 years. Recalling 4 eras of the agency and my dream for its eventual rebirth. Dr. Ward April 8, 2025
In the debate about price vs utilization as the main driver of geographic variation in cost of care, I say don’t get distracted from innovation. Dr. Ward February 21, 2025
